Canada markets closed

BeiGene, Ltd. (BGNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
198.49+2.22 (+1.13%)
At close: 04:00PM EDT
198.49 0.00 (0.00%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close196.27
Open200.00
Bid198.19 x 200
Ask198.76 x 100
Day's Range195.71 - 200.51
52 Week Range126.97 - 215.00
Volume212,446
Avg. Volume277,566
Market Cap21.943B
Beta (5Y Monthly)0.61
PE Ratio (TTM)N/A
EPS (TTM)-4.94
Earnings DateNov 07, 2024 - Nov 14, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est273.43
  • PR Newswire

    BeiGene Singapore Raises Awareness for World Lymphoma Awareness Day 2024: It's Time for Honest Talk

    BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, is proud to join the global community in raising awareness about lymphoma on World Lymphoma Awareness Day (WLAD). Lymphoma, a type of blood cancer affecting millions of people worldwide, is the focus of WLAD, which serves as a key platform during Blood Cancer Awareness Month to educate the public on the emotional and physical challenges faced by those living with the disease.

  • Simply Wall St.

    SK hynix And 2 More Stocks Estimated To Be Trading Below Fair Value

    As global markets grapple with concerns over economic slowdowns and fluctuating indices, investors are increasingly seeking opportunities in undervalued stocks. In such volatile times, identifying companies trading below their fair value can offer a strategic advantage for long-term growth.

  • Business Wire

    BeiGene Announces Updates to Commercial Leadership Team

    SAN MATEO, Calif., September 09, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Matt Shaulis as General Manager of North America, effective September 25.